Rate of Response of Individual Asthma Control Measures Varies and May Overestimate Asthma Control: An Analysis of the Goal Study
- 1 January 2007
- journal article
- clinical trial
- Published by Taylor & Francis in Journal of Asthma
- Vol. 44 (8) , 667-673
- https://doi.org/10.1080/02770900701554821
Abstract
Background: Using a composite measure based on clinical outcomes, the GOAL study showed that achievement of Total Control of asthma was time dependent with the proportion of controlled patients continuing to rise through the year-long study. Taking data from this study, we compared time taken to achieve Total Control with time taken to achieve total control of each individual clinical criterion on treatment with salmeterol/fluticasone propionate (SFC) or fluticasone propionate (FP) alone. Methods: Time to achieving total control of individual outcomes (day-time symptoms, night-time awakenings, rescue medication use, PEF ≥80% predicted every day) were analyzed by Kaplan Meier plots and compared with achievement of composite Total Control. Results: Night-time awakenings responded most rapidly and daytime symptoms took longest to respond. After 12 weeks, the proportion of patients who achieved control of any individual clinical criterion was higher than the proportion who achieved control when using the composite outcome (no night-time awakenings achieved by 73% with SFC and 65% with FP; PEF ≥80% predicted every day, 55% and 45% respectively; no rescue usage 46% and 35% respectively; and no daytime symptoms, 35% and 24% respectively, compared with Total Control, 23% and 14% respectively). In every measure except night-time awakenings, more rapid responses were seen for SFC compared with FP alone. Conclusions: Speed of response of individual asthma measures varies and evaluation of control using any single measure overestimates total asthma control. Treatment should be continued until composite control is reached, rather than control of individual outcomes.Keywords
This publication has 20 references indexed in Scilit:
- When can personal best peak flow be determined for asthma action plans?Thorax, 2004
- Can Guideline-defined Asthma Control Be Achieved?American Journal of Respiratory and Critical Care Medicine, 2004
- Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthmaThorax, 2002
- Scientific rationale for inhaled combination therapy with long-acting β2-agonists and corticosteroidsEuropean Respiratory Journal, 2002
- What are the important questions in the treatment of asthma?Clinical & Experimental Allergy Reviews, 2001
- Optimal asthma control, starting with high doses of inhaled budesonideEuropean Respiratory Journal, 2000
- Clinical Control and Histopathologic Outcome of Asthma when Using Airway Hyperresponsiveness as an Additional Guide to Long-Term TreatmentAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Lung volumes and forced ventilatory flowsEuropean Respiratory Journal, 1993
- A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroidClinical and Experimental Allergy, 1992
- Patterns of Improvement in Spirometry, Bronchial Hyperresponsiveness, and Specific IgE Antibody Levels after Cessation of Exposure in Occupational Asthma Caused by Snow-Crab ProcessingAmerican Review of Respiratory Disease, 1988